Clinical Neuroradiology

, Volume 24, Issue 2, pp 173–176 | Cite as

A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?

  • M. Berghoff
  • B. Dassinger
  • J. Iwinska-Zelder
  • M. Giraldo
  • S. Bilgin
  • M. Kaps
  • E. R. Gizewski
Correspondence

Notes

Conflict of Interest

The authors declare that there are no actual or potential conflicts of interest in relation to this article.

References

  1. 1.
    Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. Sep 10 2009;361(11):1075–80.PubMedCrossRefGoogle Scholar
  2. 2.
    Schroder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. Nov 2010;67(11):1391–4.PubMedGoogle Scholar
  3. 3.
    Sahraian MA, Radue EW, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol. 2012;19:1060–9.PubMedCrossRefGoogle Scholar
  4. 4.
    De Stefano N, Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging. Apr 2007;17(Suppl 1):31–5.CrossRefGoogle Scholar
  5. 5.
    Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology. Jul 1991;41(7):1043–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • M. Berghoff
    • 1
  • B. Dassinger
    • 2
  • J. Iwinska-Zelder
    • 2
  • M. Giraldo
    • 1
  • S. Bilgin
    • 2
  • M. Kaps
    • 1
  • E. R. Gizewski
    • 2
    • 3
  1. 1.Department of NeurologyUniversity of GiessenGiessenGermany
  2. 2.Department of NeuroradiologyUniversity of GiessenGiessenGermany
  3. 3.Clinic for NeuroradiologyMedical University InnsbruckInnsbruckAustria

Personalised recommendations